Item: Tata India Pharma & Healthcare Fund Direct Growth
Rating: Unrated
Author: Morningstar

Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth

28.506 (0.465%)

NAV on April 16, 2024

Category Equity:
Sector - Healthcare

Investment StyleBox

Large Growth

Total Assets 879 cr

Turnover Ratio 23.30%

Expense Ratio 0.83%

Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days

Returns

1M: 2.51%
1Y: 55.11%
3M: 8.04%
3Y: 18.54%
6M: 24.72%
5Y: 23.95%

Min Investment 5,000

Buy Now Start SIP

SECTOR WEIGHTINGS (%)

Financial 0.0%

Industrial 0.0%

Technology 0.0%

Basic Materials 1.87%

Consumer Cyclical 0.0%

Utilities Services 0.0%

Healthcare Services 98.13%

Energy Services 0.00%

Communication Services 0.00%

Consumer Defensive 0.00%

Real Estate 0.00%

INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

Top Rated
Top Performing

-

Best Arbitrage Fund Funds

NAME		LATEST NAV	RETURNS 1y	FUND ASSETS	Expense RATIO	RISK
Quant Healthcare Fund Direct Growth		13.715	—	265 cr	0.73%	-

Best Sector Healthcare Funds

NAME	LATEST NAV	RETURNS 1y	FUND ASSETS	Expense RATIO	RISK
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth	32.450	60.01%	3,772 cr	1.04%	-
SBI Healthcare Opportunities Fund Direct Growth	387.138	55.50%	2,626 cr	0.95%	-
Tata India Pharma & Healthcare Fund Direct Growth	28.506	55.11%	879 cr	0.83%	-
LIC MF Healthcare Fund Direct Growth	25.623	46.34%	62 cr	1.21%	-